Dergiler / Marmara Medical Journal / 2026 / Volume: 39 Issue: 3

Reversing bacterial resistance to antibiotics: Exploring natural elements and plant-derived metallo-βeta-lactamase inhibitors

Sami Ur Rehman(University of Gujrat)0009-0006-6632-7999
Zahid Anwar(University of Gujrat)0000-0002-0891-1015
Sayfa
—
Yayın Tarihi
2026-10-28
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Selected medicinal plant extracts, particularly Cymbopogon citratus, exhibit in vitro MBL inhibitory activity and can partially restore meropenem efficacy against XDR uropathogens, supporting their potential role as resistance-modifying adjuvants.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Carbapenem resistance driven by metallo-β-lactamase (MBL) production represents a major limitation in the treatment of urinary tract infections (UTIs) caused by extensively drug-resistant (XDR) bacteria.
📊
Temel Bulgular & Veri:Several plant extracts demonstrated concentration-dependent MBL inhibition, with Cymbopogon citratus showing the strongest effect.
💡
Sonuç & Katkı:Conclusion: Selected medicinal plant extracts, particularly Cymbopogon citratus, exhibit in vitro MBL inhibitory activity and can partially restore meropenem efficacy against XDR uropathogens, supporting their potential role as resistance-modifying adjuvants.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Metallo-β-lactamase · Carbapenem resistance · Cymbopogon citratus

Abstract

Objectives: Carbapenem resistance driven by metallo-β-lactamase (MBL) production represents a major limitation in the treatment of urinary tract infections (UTIs) caused by extensively drug-resistant (XDR) bacteria. The present study aimed to investigate the inhibitory effect of selected medicinal plant extracts on MBL activity and to assess their potential to enhance or partially restore the in vitro activity of meropenem against XDR uropathogenic isolates. Materials and Methods: Six carbapenem-resistant clinical isolates of Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) were phenotypically screened using the Double Disc Synergy Test (DDST) and Modified Carba-NP test, followed by molecular detection of MBL-associated genes. MBL inhibition was assessed using a modified Fe(III)–o-phenanthroline assay at graded extract concentrations. Restoration of meropenem activity was evaluated by modified DDST, and minimum bactericidal concentration (MBC) were determined for effective combinations. Statistical analysis was performed using one-way ANOVA. Results: All isolates were confirmed as MBL producers phenotypically and genetically, with frequent detection of blaNDM. Several plant extracts demonstrated concentration-dependent MBL inhibition, with Cymbopogon citratus showing the strongest effect. Selected extracts significantly enhanced meropenem activity in disc-based assays, increasing inhibition zones from baseline resistance levels. Effective combinations exhibited bactericidal activity at defined concentrations. Conclusion: Selected medicinal plant extracts, particularly Cymbopogon citratus, exhibit in vitro MBL inhibitory activity and can partially restore meropenem efficacy against XDR uropathogens, supporting their potential role as resistance-modifying adjuvants.

🔖

Bu Makaleye Atıf Yap

Rehman, S. U., Anwar, Z., Zafar, M. (2026). Reversing bacterial resistance to antibiotics: Exploring natural elements and plant-derived metallo-βeta-lactamase inhibitors. Marmara Medical Journal, Volume: 39 Issue: 3. https://doi.org/10.5472/marumj.2071777

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (86)

  1. Shrestha A, Acharya J, Amatya J, Paudyal R, Rijal N. Detection of beta-lactamases (ESBL and MBL) producing gram-negative pathogens in National Public Health Laboratory of Nepal. Int J Microbiol 2022;2022:1-7. doi:10.1155/2022/5474388
  2. Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging treatment options for multi-drug-resistant bacterial infections. Life 2021;11:519. doi:10.3390/life11060519
  3. Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-resistant sepsis: A critical healthcare challenge. Antibiotics 2024;13:46. doi:10.3390/antibiotics13010046
  4. Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62:499-513. doi:10.1099/jmm.0.052555-0
  5. Ali SR, Pandit S, De M. 2D-MoS2-Based β-Lactamase Inhibitor for Combination Therapy against Drug-Resistant Bacteria. ACS Appl Bio Mater 2018;1:967-74. doi:10.1021/acsabm.8b00105
  6. Magryś A, Olender A, Tchórzewska D. Antibacterial properties of Allium sativum L. against the most emerging multidrug-resistant bacteria and its synergy with antibiotics. Arch Microbiol 2021;203:2257-68. doi:10.1007/s00203-021-02248-z
  7. Pal A, Tripathi A. Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem resistant Escherichia coli and Klebsiella pneumoniae. Microb Pathog 2020;143:104120. doi:10.1016/j.micpath.2020.104120
  8. Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing new antimicrobial therapies: Are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? Pharmacogn Rev 2017;11:57-72. doi:10.4103/phrev.phrev_21_17
  9. González‐Pastor R, Carrera-Pacheco SE, Zúñiga-Miranda J, et al. Current Landscape of Methods to Evaluate Antimicrobial Activity of Natural Extracts. Molecules 2023;28:1068. doi:10.3390/molecules28031068
  10. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281. doi:10.1111/j.1469-0691.2011.03570.x
  11. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). MIC and zone distributions and ECOFFs. Available from: eucast.org [Accessed 2026].
  12. Holding AJ, Collee JG. Routine biochemical tests. In: Norris JR, Ribbons DW, editors. Methods in Microbiology. Volume 6A. London: Elsevier; 1971:1-32. doi:10.1016/s0580-9517(08)70573-7
  13. Uyanga FZ, Ekundayo EO, Nwankwo EO, Inimfon AI. Evaluation of CHROMagar ESBL and Double Disk Synergy Test (DDST) for screening of extended spectrum beta-lactamase producing uropathogens in South-South Nigeria. J Adv Microbiol 2019;17:1-11. doi:10.9734/jamb/2019/v17i430154
  14. Chowdhury RA, Sharmin S, Chowdhury AHMSK, Akter N, Ahmed S, Choudhury GN. Comparison of combined disc synergy test and double disc synergy test for phenotypic detection of metallo-ß-lactamase among the clinical isolates of gram-negative bacilli. Int J Res Med Sci 2022;10:1402-7. doi:10.18203/2320-6012.ijrms20221782
  15. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012;18:1503-7. doi:10.3201/eid1809.120355
  16. Flores C, Bianco K, de Filippis I, et al. Genetic relatedness of NDM-producing Klebsiella pneumoniae co-occurring VIM, KPC, and OXA-48 Enzymes from surveillance cultures from an intensive care unit. Microb Drug Resist 2020;26:1219-26. doi:10.1089/mdr.2019.0483
  17. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother 2007;59:321-2. doi:10.1093/jac/dkl481
  18. Ali MR, Al-Taai HRR, AL-Nuaeyme HA, Khudhair AM. Molecular study of genetic diversity in Escherichia coli isolated from different clinical sources. Plant Archives 2020;20:3319-23.
  19. Kohl P, Zingl FG, Eichmann TO, et al. Isolation of outer membrane vesicles including their quantitative and qualitative analyses. Methods Mol Biol 2018;1841:117-34. doi:10.1007/978-1-4939-8685-9_11
  20. Masi M, Réfregiers M, Pos KM, et al. Understanding antibiotic resistance via outer membrane permeability. Infect Drug Resist 2017;10:321-31. doi:10.2147/idr.s156995
  21. Klimentová J, Stulík J. Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria. Microbiol Res 2015;170:1-9. doi:10.1016/j.micres.2014.09.006
  22. Kruger NJ. The Bradford Method For Protein Quantitation. In: Walker JM, editor. The Protein Protocols Handbook. Totowa, NJ: Humana Press; 2009. p. 17–24. doi:10.1007/978-1-59745-198-7_4
  23. Bonjoch NP, Tamayo PR. Protein content quantification by Bradford Method. In: Reigosa Roger MJ, editor. Handbook of Plant Ecophysiology Techniques. Dordrecht: Springer Netherlands, 2001: 283-95. doi:10.1007/0-306-48057-3_19
  24. Singh DK, Maheshwari G. Development and validation of spectrophotometric methods for carbapenems in pharmaceutical dosage forms. Med Chem Res 2013;22:5434-41. doi:10.1007/s00044-013-0522-7
  25. Homoda AM, Kamel MS, Khaled E. New spectrophotometric microdetermination of carbapenem antibiotics derivatives in pharmaceutical formulations. J Taibah Univ Sci 2016;10:19-25. doi:10.1016/j.jtusci.2015.03.005
  26. Singh DK, Maheshwari G. Development and validation of spectrophotometric methods for carbapenems in pharmaceutical dosage forms. Med Chem Res 2013;22:5442-50. doi:10.1007/s00044-013-0522-7
  27. Al-Momani IF. Spectrophotometric determination of selected cephalosporins in drug formulations using flow injection analysis. J Pharm Biomed Anal 2001;25:751-7. doi:10.1016/S0731-7085(01)00368-5
  28. Mahmood AH, Mahmood HS. A new spectrophotometric approach for determination of meropenem in pharmaceutical formulation. Rafidain J Sci 2023;32:9-20. doi:10.33899/rjs.2023.180272
  29. Kim HJ, Jang S. Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae. 3 Biotech 2018;8:3. doi:10.1007/s13205-017-1034-9
  30. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2023.
  31. Lee YL, Chen HM, Hii IM, Hsueh PR. Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment. Int J Antimicrob Agents 2022;59:106528. doi:10.1016/j.ijantimicag.2022.106528
  32. Amir N, Elizabeth T, Jonathan L, et al. Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial. Antimicrob Resist Infect Control 2025;14:42. doi:10.1186/s13756-025-01651-1
  33. Chandar B, Poovitha S, Ilango K, et al. Inhibition of New Delhi Metallo-β-Lactamase 1 (NDM-1) producing Escherichia coli IR-6 by selected plant extracts and their synergistic actions with antibiotics. Front Microbiol 2017;8:1580. doi:10.3389/fmicb.2017.01580
  34. Zarfel G, Hoenigl M, Leitner E, et al. Emergence of New Delhi Metallo-β-Lactamase, Austria. Emerg Infect Dis 2011;17:129-30. doi:10.3201/eid1701.101331
  35. Aoki N, Ishii Y, Tateda K, et al. Efficacy of calcium-EDTA as an inhibitor for Metallo-β-Lactamase in a mouse model of pseudomonas aeruginosa pneumonia. Antimicrob Agents Chemother 2010;54:4582-8. doi:10.1128/AAC.00511-10
  36. Sfeir MM, Hayden JA, Fauntleroy KA, et al. EDTA-modified carbapenem inactivation method: a phenotypic method for detecting Metallo-β-Lactamase-producing enterobacteriaceae. J Clin Microbiol 2019;57:e01757-18. doi:10.1128/JCM.01757-18
  37. Bouslah Z, El Amari EB, Touati A. Carba NP test for the detection of carbapenemase-producing Pseudomonas aeruginosa. Med Mal Infect 2020;50:466-79. doi:10.1016/j.medmal.2019.12.002
  38. Datta S, Dey R, Dey JB, Ghosh S. A comparative study of modified Hodge test and Carba NP test for detecting carbapenemase production in Gram-negative bacteria. Med J Dr DY Patil Univ 2017;10:365-9. doi:10.4103/0975-2870.213930
  39. Kumar N, Singh VA, Beniwal V, Pottathil S. Modified Carba NP Test: Simple and rapid method to differentiate KPC‐ and MBL‐producing Klebsiella species. J Clin Lab Anal 2018;32:e22448. doi:10.1002/jcla.22448
  40. Matsumura Y, Pitout JD. Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae. Expert Rev Mol Diagn 2016;16:783-94. doi:10.1586/14737159.2016.1172964
  41. Rashed NS, Abdelazeem AM, Fouad FA. Spectrophotometric methods for the determination of ceftiofur and tulathromycin in bulk and dosage forms. Asian J Appl Chem Res 2020;5:34-47. doi:10.9734/ajacr/2020/v5i130126
  42. Cheikhyoussef A, Cheikhyoussef N, Rahman A, Hussein AA. Clove (Syzygium aromaticum) phenolics: Extraction, compositions, and biological activities. In: Clove (Syzygium Aromaticum). London: Elsevier, 2022:215-33. doi:10.1016/b978-0-323-85177-0.00036-7
  43. Shrivastav A, Sharma RK, Shrivastava N, et al. Study of inhibitory potential and percent inhibition of oil of Syzygium aromaticum and leaves of Ocimum sanctum on ESBL enzyme from Escherichia coli in broilers of Jabalpur. Indian J Pharmacol 2019;51:337-42. doi:10.4103/ijp.IJP_87_17
  44. Klančnik A, Piskernik S, Jeršek B, Možina SS. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J Microbiol Methods 2010;81:121-6. doi:10.1016/j.mimet.2010.02.004
  45. Samreen A I. Anti-infective synergy of Acacia nilotica bioactive fraction and methyl gallate with meropenem against pathogenicity of Pseudomonas aeruginosa. 3 Biotech 2025;15:209. doi:10.1007/s13205-025-04372-9
  46. Soukarieh F, Mashabi A, Richardson W, et al. Design, Synthesis, and Evaluation of New 1H-Benzo[d]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. J Med Chem 2024;67:1008-23. doi:10.1021/acs.jmedchem.3c00973
  47. Aonofriesei F, Sampaio AC, Stanciu G, Lupsor S. Antibacterial properties of hemiaminal of 2-methylimidazole and its interaction with ionic and nonionic surfactants. Farmacia 2021;69:2. doi:10.31925/farmacia.2021.2.15
  48. Sarker SD, Nahar L, Kumarasamy Y. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 2007;42:321-4. doi:10.1016/j.ymeth.2007.01.006
  49. Alam M, Bano N, Ahmad T, et al. Synergistic role of plant extracts and essential oils against multidrug resistance and Gram-negative bacterial strains producing extended-spectrum β-lactamases. Antibiotics (Basel) 2022;11:855. doi:10.3390/antibiotics11070855
  50. Pal A, Tripathi A. Quercetin potentiates meropenem activity among pathogenic carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. J Appl Microbiol 2019;127:1038-47. doi:10.1111/jam.14388
  51. Shrestha A, Acharya J, Amatya J, Paudyal R, Rijal N. Detection of beta-lactamases (ESBL and MBL) producing gram-negative pathogens in National Public Health Laboratory of Nepal. Int J Microbiol 2022;2022:1-7. doi:10.1155/2022/5474388
  52. Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging treatment options for multi-drug-resistant bacterial infections. Life 2021;11:519. doi:10.3390/life11060519
  53. Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-resistant sepsis: A critical healthcare challenge. Antibiotics 2024;13:46. doi:10.3390/antibiotics13010046
  54. Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62:499-513. doi:10.1099/jmm.0.052555-0
  55. Ali SR, Pandit S, De M. 2D-MoS2-Based β-Lactamase Inhibitor for Combination Therapy against Drug-Resistant Bacteria. ACS Appl Bio Mater 2018;1:967-74. doi:10.1021/acsabm.8b00105
  56. Magryś A, Olender A, Tchórzewska D. Antibacterial properties of Allium sativum L. against the most emerging multidrug-resistant bacteria and its synergy with antibiotics. Arch Microbiol 2021;203:2257-68. doi:10.1007/s00203-021-02248-z
  57. Pal A, Tripathi A. Demonstration of bactericidal and synergistic activity of quercetin with meropenem among pathogenic carbapenem resistant Escherichia coli and Klebsiella pneumoniae. Microb Pathog 2020;143:104120. doi:10.1016/j.micpath.2020.104120
  58. Cheesman MJ, Ilanko A, Blonk B, Cock IE. Developing new antimicrobial therapies: Are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? Pharmacogn Rev 2017;11:57-72. doi:10.4103/phrev.phrev_21_17
  59. González‐Pastor R, Carrera-Pacheco SE, Zúñiga-Miranda J, et al. Current Landscape of Methods to Evaluate Antimicrobial Activity of Natural Extracts. Molecules 2023;28:1068. doi:10.3390/molecules28031068
  60. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281. doi:10.1111/j.1469-0691.2011.03570.x
  61. Uyanga FZ, Ekundayo EO, Nwankwo EO, Inimfon AI. Evaluation of CHROMagar ESBL and Double Disk Synergy Test (DDST) for screening of extended spectrum beta-lactamase producing uropathogens in South-South Nigeria. J Adv Microbiol 2019;17:1-11. doi:10.9734/jamb/2019/v17i430154
  62. Chowdhury RA, Sharmin S, Chowdhury AHMSK, Akter N, Ahmed S, Choudhury GN. Comparison of combined disc synergy test and double disc synergy test for phenotypic detection of metallo-ß-lactamase among the clinical isolates of gram-negative bacilli. Int J Res Med Sci 2022;10:1402-7. doi:10.18203/2320-6012.ijrms20221782
  63. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012;18:1503-7. doi:10.3201/eid1809.120355
  64. Flores C, Bianco K, de Filippis I, et al. Genetic relatedness of NDM-producing Klebsiella pneumoniae co-occurring VIM, KPC, and OXA-48 Enzymes from surveillance cultures from an intensive care unit. Microb Drug Resist 2020;26:1219-26. doi:10.1089/mdr.2019.0483
  65. Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother 2007;59:321-2. doi:10.1093/jac/dkl481
  66. Ali MR, Al-Taai HRR, AL-Nuaeyme HA, Khudhair AM. Molecular study of genetic diversity in Escherichia coli isolated from different clinical sources. Plant Archives 2020;20:3319-23.
  67. Kohl P, Zingl FG, Eichmann TO, et al. Isolation of outer membrane vesicles including their quantitative and qualitative analyses. Methods Mol Biol 2018;1841:117-34. doi:10.1007/978-1-4939-8685-9_11
  68. Masi M, Réfregiers M, Pos KM, et al. Understanding antibiotic resistance via outer membrane permeability. Infect Drug Resist 2017;10:321-31. doi:10.2147/idr.s156995
  69. Klimentová J, Stulík J. Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria. Microbiol Res 2015;170:1-9. doi:10.1016/j.micres.2014.09.006
  70. Kruger NJ. The Bradford Method For Protein Quantitation. In: Walker JM, editor. The Protein Protocols Handbook. Totowa, NJ: Humana Press; 2009. p. 17–24. doi:10.1007/978-1-59745-198-7_4
  71. Singh DK, Maheshwari G. Development and validation of spectrophotometric methods for carbapenems in pharmaceutical dosage forms. Med Chem Res 2013;22:5434-41. doi:10.1007/s00044-013-0522-7
  72. Homoda AM, Kamel MS, Khaled E. New spectrophotometric microdetermination of carbapenem antibiotics derivatives in pharmaceutical formulations. J Taibah Univ Sci 2016;10:19-25. doi:10.1016/j.jtusci.2015.03.005
  73. Singh DK, Maheshwari G. Development and validation of spectrophotometric methods for carbapenems in pharmaceutical dosage forms. Med Chem Res 2013;22:5442-50. doi:10.1007/s00044-013-0522-7
  74. Al-Momani IF. Spectrophotometric determination of selected cephalosporins in drug formulations using flow injection analysis. J Pharm Biomed Anal 2001;25:751-7. doi:10.1016/S0731-7085(01)00368-5
  75. Mahmood AH, Mahmood HS. A new spectrophotometric approach for determination of meropenem in pharmaceutical formulation. Rafidain J Sci 2023;32:9-20. doi:10.33899/rjs.2023.180272
  76. Kim HJ, Jang S. Optimization of a resazurin-based microplate assay for large-scale compound screenings against Klebsiella pneumoniae. 3 Biotech 2018;8:3. doi:10.1007/s13205-017-1034-9
  77. Lee YL, Chen HM, Hii IM, Hsueh PR. Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment. Int J Antimicrob Agents 2022;59:106528. doi:10.1016/j.ijantimicag.2022.106528
  78. Amir N, Elizabeth T, Jonathan L, et al. Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial. Antimicrob Resist Infect Control 2025;14:42. doi:10.1186/s13756-025-01651-1
  79. Chandar B, Poovitha S, Ilango K, et al. Inhibition of New Delhi Metallo-β-Lactamase 1 (NDM-1) producing Escherichia coli IR-6 by selected plant extracts and their synergistic actions with antibiotics. Front Microbiol 2017;8:1580. doi:10.3389/fmicb.2017.01580
  80. Sfeir MM, Hayden JA, Fauntleroy KA, et al. EDTA-modified carbapenem inactivation method: a phenotypic method for detecting Metallo-β-Lactamase-producing enterobacteriaceae. J Clin Microbiol 2019;57:e01757-18. doi:10.1128/JCM.01757-18
  81. Bouslah Z, El Amari EB, Touati A. Carba NP test for the detection of carbapenemase-producing Pseudomonas aeruginosa. Med Mal Infect 2020;50:466-79. doi:10.1016/j.medmal.2019.12.002
  82. Kumar N, Singh VA, Beniwal V, Pottathil S. Modified Carba NP Test: Simple and rapid method to differentiate KPC‐ and MBL‐producing Klebsiella species. J Clin Lab Anal 2018;32:e22448. doi:10.1002/jcla.22448
  83. Matsumura Y, Pitout JD. Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae. Expert Rev Mol Diagn 2016;16:783-94. doi:10.1586/14737159.2016.1172964
  84. Rashed NS, Abdelazeem AM, Fouad FA. Spectrophotometric methods for the determination of ceftiofur and tulathromycin in bulk and dosage forms. Asian J Appl Chem Res 2020;5:34-47. doi:10.9734/ajacr/2020/v5i130126
  85. Klančnik A, Piskernik S, Jeršek B, Možina SS. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. J Microbiol Methods 2010;81:121-6. doi:10.1016/j.mimet.2010.02.004
  86. Pal A, Tripathi A. Quercetin potentiates meropenem activity among pathogenic carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. J Appl Microbiol 2019;127:1038-47. doi:10.1111/jam.14388